Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

Summary & key facts

Researchers gave ketamine to people with major depression that had not improved with standard treatments in a carefully controlled study at two sites. They found that ketamine produced fast antidepressant effects, meaning people showed improvement soon after treatment. The results suggest a new brain mechanism (called NMDA receptor modulation) might explain how ketamine works. The researchers warn that we still need more information about how long the benefits last and about safety before this can become a routine treatment.

Key facts:

• The study tested ketamine in people with treatment-resistant major depression, meaning their depression had not gotten better with usual treatments.
• Ketamine produced rapid antidepressant effects, so people improved soon after receiving the drug.
• The findings support the idea that changing activity at the brain's NMDA receptor (a protein involved in how brain cells signal each other) can lead to faster improvement in severe, long-standing depression.
• The study design was optimized and carefully controlled and was done at two separate sites to strengthen the findings.
• The researchers said more information is needed about how long the antidepressant response lasts and about ketamine's safety before it can be used routinely in clinical practice.

Abstract

Ketamine demonstrated rapid antidepressant effects in an optimized study design, further supporting NMDA receptor modulation as a novel mechanism for accelerated improvement in severe and chronic forms of depression. More information on response durability and safety is required before implementation in clinical practice.

Topics

Neuroscience and Neuropharmacology Research Treatment of Major Depression Tryptophan and brain disorders

Categories

Health Sciences Medicine Pharmacology

Tags

Anesthesia Antidepressant Depression (economics) Economics Glutamate receptor Hippocampus Internal medicine Ketamine Macroeconomics Medicine Pharmacology Randomized controlled trial Receptor Treatment-resistant depression

Substances

Ketamine

Conditions & symptoms

Depression Sadness or low mood